• News & Media
  • Contact
  • Home
  • About Us
    • Our Commitment
    • The Story Behind Our Name
    • Leadership
    • Board of Directors
  • Our Approach
    • Precision Medicines
    • Overcoming Resistance
    • Novel Biomarkers
  • Pipeline
    • Ziftomenib
    • Tipifarnib
    • KO-2806
    • Posters and Presentations
    • Scientific Manuscripts
    • Access To Investigational Drugs Outside a Clinical Study
  • Clinical Trials
    • Overview of Clinical Trials
    • Ziftomenib Clinical Trials
    • KOMET-001 – AML
    • KOMET-007 – AML
    • KOMET-008 – AML
    • Tipifarnib Clinical Trials
    • KURRENT-HN – HNSCC
    • KO-2806 Clinical Trials
    • FIT-001 – Solid Tumors
  • Patients & Caregivers
    • Acute Leukemias
    • Head & Neck Cancer
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • FAQs
    • Contact
  • Careers
    • Values
    • Life At Kura
    • Benefits
    • Open Positions
  • News & Media
  • Contact
  • Menu Menu

Fostering a Workplace Place for Innovators to Thrive

September 17, 2024/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/Kura-Fast-Company-LinkedIn.png 644 1200 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-09-17 10:48:032024-09-17 10:48:03Fostering a Workplace Place for Innovators to Thrive

Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends

February 15, 2024/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/SC2402_Scrip-Asks-24-Part-5_1888758571_1200.jpg 444 790 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-02-15 13:42:192024-02-15 13:42:19Scrip Asks…What Does 2024 Hold For Biopharma? Part 5: Clinical Trial Trends

PharmaVoice’s Crystal Ball: Perspectives on the financial future

January 9, 2024/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/PV-Outlook.png 852 1524 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2024-01-09 10:38:132024-01-09 10:38:13PharmaVoice’s Crystal Ball: Perspectives on the financial future

Kathy Ford, R.N., B.S.N., Kura COO, on Ordinarily Extraordinary – Conversations with Women in STEM podcast

December 20, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/kathy-ford-ordinarily-extraordinary-podcast.jpg 792 2102 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-12-20 17:13:012023-12-21 15:44:40Kathy Ford, R.N., B.S.N., Kura COO, on Ordinarily Extraordinary – Conversations with Women in STEM podcast

Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place

December 1, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/Manu_Supply_Chain.jpg 375 710 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-12-01 13:58:582023-12-08 13:59:45Manufacturing And Supply Chain: Making Space Between A Rock And A Hard Place

The Promise of Precision Oncology, Troy Wilson, President & CEO, Kura Oncology

November 29, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/Biotech_2050-185.jpg 375 710 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-11-29 14:59:252023-12-07 11:37:51The Promise of Precision Oncology, Troy Wilson, President & CEO, Kura Oncology

Kura Oncology’s CEO gives an update on Q3 earnings

November 2, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/q3_earnings_image.png 1294 2300 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-11-02 08:00:172023-11-03 14:32:44Kura Oncology’s CEO gives an update on Q3 earnings

PharmaVoice 100 Top Industry Leaders: Teresa Bair, J.D.

September 19, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/teresa-bair_pv100_09012381977.png 960 1706 David Anderson /wp-content/uploads/kura-logo-registered-blue.svg David Anderson2023-09-19 09:17:432023-09-20 14:45:07PharmaVoice 100 Top Industry Leaders: Teresa Bair, J.D.

San Diego Business Journal Leaders of Influence in Life Sciences 2023 Honorees

July 24, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/SDBJ_Honoree.jpg 375 710 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-07-24 12:29:582023-07-24 15:17:14San Diego Business Journal Leaders of Influence in Life Sciences 2023 Honorees

San Diego Business Journal CEO of the Year Awards 2023 Finalists

June 22, 2023/in Leadership In The News
Read more
https://kuraoncology.com/wp-content/uploads/troy_wilson_lab.png 478 850 eallison /wp-content/uploads/kura-logo-registered-blue.svg eallison2023-06-22 18:08:582023-06-22 18:11:48San Diego Business Journal CEO of the Year Awards 2023 Finalists
Page 1 of 212
  • About Us
  • Our Commitment
  • The Story Behind Our Name
  • Leadership
  • Board of Directors
  • Our Approach
  • Precision Medicines
  • Overcoming Resistance
  • Novel Biomarkers
  • Pipeline
  • Ziftomenib
  • Tipifarnib
  • KO-2806
  • Posters and Presentations
  • Scientific Manuscripts
  • Access to Investigational Drugs Outside a Clinical Study
  • Clinical Trials
  • Overview of Clinical Trials
  • Ziftomenib Clinical Trials
  • KOMET-001 – AML
  • KOMET-007 – AML
  • KOMET-008 – AML
  • Tipifarnib Clinical Trials
  • KURRENT-HN – HNSCC
  • KO-2806 Clinical Trials
  • FIT-001 – Solid Tumors
  • Patients & Caregivers
  • Acute Leukemias
  • Head & Neck Cancer
  • Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financial Information
  • Analyst Coverage
  • FAQs
  • Contact
  • Careers
  • Values
  • Life at Kura
  • Benefits
  • Open Positions
  • News & Media
  • Press Releases
  • News & Perspectives
  • Expert Perspectives
  • Media Resources
  • Contact

Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
(858) 500-8800

Kura Oncology, Inc.
2 Seaport Lane, Suite 8A
Boston, MA 02210
(617) 588-3755

Kura Oncology, Inc.
5510 Morehouse Drive, Suite 110
San Diego, California 92121

© 2025 Kura Oncology, Inc. All Rights Reserved | Terms of Use | Privacy Policy

Scroll to top Scroll to top Scroll to top